Ledger.Open graph →
SEC Form D · filed January 27, 2020

Novus Therapeutics, Inc

Offering
$5.8M
Sold
$862K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Irvine, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Cheryl Cohen · Irvine, CADirectorErez Chimovits · Irvine, CADirectorJon Kuwahara · Irvine, CAExecKeith Katkin · Irvine, CADirectorJohn Mcbride · Irvine, CADirectorCatherine Turkel · Irvine, CAExecGregory Flesher · Irvine, CAExec · DirectorGary Lyons · Irvine, CADirectorRichard H. Hardwick · Dallas, TXExec · DirectorJerret H. Shuck · Dallas, TXExecCorey D. Linn · KENNEDY SPACE CENTER, FLExecJames F. Connor · Menlo Park, CADirectorMatthew E. Rydell · Dallas, TXDirectorFrederick Brumder · Bend, ORDirectorJohn Lykouretzos · NEW YORK, NYDirectorPaolo Crozzoli · Luxembourg, LuxembourgDirectorStefan Goetz · London, United KingdomExecCharles Laurans · Boston, MAExec · DirectorAndrew D. Cooper · Phoenix, AZDirectorKen Miller · ROXBORO, NCDirectorKathleen L. Herrin · Chicago, ILDirectorAlphonse L. Iudicello · Chicago, ILDirector[No Name] Boyd Watterson GSA GP, LLC · Cleveland, OHDirector[No Name] Boyd Watterson Asset Management, LLC · Cleveland, OHExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗